The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; Novartis; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Novartis; Pfizer; Roche
Research Funding - Tesaro
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Pfizer; Roche
Phase 1b/2 study of ladiratuzumab vedotin (LV) in combination with pembrolizumab for first-line treatment of triple-negative breast cancer (SGNLVA-002, trial in progress).
 
Jane Lowe Meisel
Honoraria - Medscape; Total Health Conferencing
Consulting or Advisory Role - AstraZeneca; Curio Science; Genentech; GlaxoSmithKline; Novartis; Seagen
Research Funding - Pfizer; Seagen
Travel, Accommodations, Expenses - Pfizer; Puma Biotechnology; Total Health Conferencing
 
Timothy J. Pluard
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Genentech; Gilead Sciences; H3 Biomedicine; Macrogenics; Novartis; Pfizer; Seagen
Speakers' Bureau - Genentech/Roche; Gilead Sciences; Novartis; Seagen
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); DAEHWA Pharmaceutical (Inst); Dantari (Inst); G1 Therapeutics (Inst); H3 Biomedicine (Inst); HiberCell (Inst); Olema Pharmaceuticals (Inst); Orinove (Inst); Orinove (Inst); Pfizer (Inst); Sanofi (Inst); Seagen (Inst); Zymeworks (Inst)
 
Shaveta Vinayak
Consulting or Advisory Role - OncoSec
Research Funding - OncoSec (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Seagen (Inst)
 
Erica Michelle Stringer-Reasor
Honoraria - Breast Cancer Index; Lilly; Mylan
Consulting or Advisory Role - AstraZeneca; Immunomedics; Lilly; Merck; Novartis; OncoSec; Seagen
Speakers' Bureau - Lilly
Research Funding - Susan G. Komen for the Cure; V Foundation
Travel, Accommodations, Expenses - Cascadian Therapeutics; Lilly
(OPTIONAL) Uncompensated Relationships - Genentech
 
Ursa Brown-Glaberman
Consulting or Advisory Role - Biotheranostics; Macrogenics; Novartis; Sanofi/Aventis; Seagen; Taiho Oncology
Research Funding - Seagen (Inst)
 
Patrick Michael Dillon
Research Funding - Abbvie (Inst); Merck (Inst); Newlink Genetics (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Tesaro (Inst); Tolero Pharmaceuticals (Inst)
 
Reva K Basho
Employment - Alignment Healthcare (I)
Stock and Other Ownership Interests - Alignment Healthcare (I)
Consulting or Advisory Role - AstraZeneca; AstraZeneca; bioTheranostics; Pfizer; Seagen
Speakers' Bureau - Seagen
Research Funding - Ichnos Sciences (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst); Takeda (Inst)
Other Relationship - MJH Healthcare Holdings, LLC
(OPTIONAL) Uncompensated Relationships - Novartis
 
Ramya Varadarajan
No Relationships to Disclose
 
Joyce O'Shaughnessy
Honoraria - Abbvie; Agendia; Amgen; Aptitude Health; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Clovis Oncology; Daiichi Sankyo; Eisai; G1 Therapeutics; Genentech; Gilead Sciences; GRAIL; Halozyme; HERON; Immunomedics; Ipsen; Lilly; Merck; Myriad Pharmaceuticals; Nektar; Novartis; Pfizer; Pharmacyclics; Pierre Fabre; Prime Oncology; Puma Biotechnology; Roche; Samsung; Sanofi; Seagen; Syndax; Synthon; Taiho Oncology; Takeda
Consulting or Advisory Role - Abbvie; Agendia; Amgen; Aptitude Health; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Clovis Oncology; Daiichi Sankyo; Eisai; G1 Therapeutics; Genentech; Gilead Sciences; GRAIL; Halozyme; HERON; Immunomedics; Ipsen; Lilly; Merck; Myriad Pharmaceuticals; Nektar; Novartis; Pfizer; Pharmacyclics; Pierre Fabre; Prime Oncology; Puma Biotechnology; Roche; Samsung; Sanofi; Seagen; Syndax; Synthon; Taiho Oncology; Takeda
Speakers' Bureau - AstraZeneca; Lilly; Novartis; Pfizer
Research Funding - Seagen (Inst)
Travel, Accommodations, Expenses - Abbvie; Agendia; Amgen; AstraZeneca; Celgene; Eisai; GRAIL; Ipsen; Lilly; Myriad Pharmaceuticals; Novartis; Pfizer; Puma Biotechnology; Roche; Sanofi; Seagen
 
Hyo S. Han
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca; Immunomedics; Immunomedics/Gilead; Novartis
Speakers' Bureau - Lilly
Research Funding - Abbvie (Inst); Arvinas (Inst); Department of Defense (Inst); G1 Therapeutics (Inst); GlaxoSmithKline (Inst); Horizon Oncology Research (Inst); Marker Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Phoenix Pharmaceuticals (Inst); QuantumLeap Health (Inst); Seagen (Inst); Zymeworks (Inst)
 
Rajni Sinha
No Relationships to Disclose
 
Jenny R. Fox
Stock and Other Ownership Interests - Rocky Mountain Cancer Centers
 
Rafael Villanueva
Consulting or Advisory Role - Novartis
Speakers' Bureau - Lilly; Novartis
Expert Testimony - Novartis
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Eisai; Lilly; Novartis; Roche
 
Lin Chi Chen
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Sheng Wu
Employment - Seagen
Stock and Other Ownership Interests - Seagen
 
Hong Li
Employment - Seagen
Stock and Other Ownership Interests - Seagen
 
Sinhan Tran
Employment - Seagen
Stock and Other Ownership Interests - Seagen
 
Luis Manso
No Relationships to Disclose